A Convenient Synthesis and Chemical Properties of 3-Acylamino-6-polyfluoroalkyl-2<i>H</i>-pyran-2-ones
作者:Igor I. Gerus、Günter Haufe、Nataliya A. Tolmachova、Sergey I. Vdovenko、Roland Fröhlich
DOI:10.1055/s-2005-865290
日期:——
A number of 3-acylamino-6-polyfluoroalkyl-2H-pyran-2-ones 3 were synthesized from β-alkoxyvinyl polyfluoroalkyl ketones 1 and N-acylglycines 2 in acetic anhydride in high yield. The reactions of trifluoromethyl-containing 2H-pyran-2-one 3b with O- and N-nucleophiles were studied and 3-N-benzoylamino-6-hydroxy-6-trifluoromethyl-5,6-dihydro-2H-pyran-2-one (13), 3-N-benzoylamino-6-hydroxy-6-trifluoromethyl-5,6-dihydro-2H-pyridin-2-one (14a), and N- and O-substituted 3-(N-benzoylamino)-6-trifluoromethyl-2H-pyridin-2-ones (15c,e, and 16) were synthesized.
A series of eperezolidanalogs with glycinylsubstitutions were prepared and their antibacterialactivities were studied against a panel of susceptible and resistant Gram‐positive bacteria. The compounds with N‐arylacyl or N‐heteroarylacyl glycinyl structural units showed good antibacterialactivities. The compounds 11b, 11c, and 11e were twofold more active than linezolid against Staphylococcus epidermidis
制备了一系列具有甘氨酰基取代的 eperezolid 类似物,并研究了它们对一组敏感和耐药革兰氏阳性细菌的抗菌活性。具有N-芳酰基或N-杂芳酰基甘氨酰基结构单元的化合物表现出良好的抗菌活性。化合物 11b、11c 和 11e 对表皮葡萄球菌和粪肠球菌的活性是利奈唑胺的两倍。还制备了几种吡啶类似物,发现对大多数测试的革兰氏阳性细菌的抗菌活性较差,但是,其中一种化合物 12e 对粪肠球菌表现出非常高的活性。
NOVEL COMPOUND AND COMPOSITION FOR PREVENTION OR TREATMENT OF RESPIRATORY DISEASES COMPRISING SAME AS ACTIVE INGREDIENT
The present invention relates to a novel compound, and a composition for preventing or treating of respiratory disease comprising the novel compound, E- or Z-isomer thereof, optical isomer thereof, a mixture of two isomers thereof, precursor thereof, pharmaceutically acceptable salt thereof or solvate thereof as an active ingredient.
[EN] 2-BENZOYLAMINO-3-PHENYLPROPENAMIDE DERIVATIVES AND METHODS OF USING THE SAME<br/>[FR] DERIVES DE 2-BENZOYLAMINO-3-PHENYLPROPENAMIDE ET LEURS PROCEDES D'UTILISATION
申请人:AVID THERAPEUTICS INC.
公开号:WO1998033501A1
公开(公告)日:1998-08-06
(EN) Novel 2-Benzoylamino-3-phenylpropenamides are disclosed as antiviral agents. Compositions containing the 2-benzoylamino-3-phenylpropenamides and methods for treating viral diseases, such as hepatitis, with 2-benzoylamino-3-phenylpropenamides are also disclosed.(FR) L'invention concerne de nouveaux 2-benzoylamino-3-phénylpropénamides servant d'agents antiviraux. L'invention concerne également des compositions contenant lesdits 2-benzoylamino-3-phénylpropénamides et des méthodes pour traiter des maladies virales, telles que l'hépatite, au moyen desdits 2-benzoylamino-3-phénylpropénamides.
[EN] METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1<br/>[FR] PROCÉDÉS ET COMPOSÉS POUR MODULER UNE DYSTROPHIE MYOTONIQUE DE TYPE 1
申请人:DESIGN THERAPEUTICS INC
公开号:WO2022126000A1
公开(公告)日:2022-06-16
The present disclosure relates to transcription modulator molecule compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role. The transcription modulator comprising a) the first terminus comprising a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) a second terminus comprising a protein-binding moiety capable of binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) an oligomeric backbone comprising a linker between the first terminus and the second terminus.